NAS:CRSP (Switzerland) Also Trade In: Germany Mexico UK

CRISPR Therapeutics AG $ 0 2.49 (2.76%)

Volume:
0
Avg Vol (1m):
962,406
Market Cap $:
6.50 Bil
Enterprise Value $:
5.61 Bil
P/E (TTM):
201.41
P/B:
6.36
Warning! GuruFocus has detected 2 Severe warning signs with CRSP. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 10Y (-%)

CRISPR Therapeutics AG News and Headlines -

GuruFocus Articles Total 5
  • 1

Companies already have an agreement on cancer drug

On Oct. 19, I reviewed three of the 10 companies a Jeffries health care analyst thinks are most likely to be acquired by members of Big Pharma. Now let's look at numbers four through six on the list Jeffries' Jaret Holtz provided to FierceBiotech.

Bluebird Bio Inc. (BLUE) - Cambridge, Massachusetts

A logical acquirer is Bristol-Myers Squibb Co. (BMY) given the two already have an agreement on a Bluebird cancer drug, which Bristol obtained as part of its takeover of Celgene. The agreement was recently modified when Bristol gave Bluebird $200 million to beef up its manufacturing in exchange

275 Views    Barry Cohen    2020-10-20 22:17
New model can increase accuracy 50-fold

Gene-editing stocks may soon take a leap forward with the discovery of what is being billed as a one-size-fits-all DNA lock.

The three pure-play CRISPR stocks have been on the decline since early 2018. Shares of Intellia Therapeutics (NTLA), Editas Medicine (EDIT) and leader CRISPR Therapeutics (CRSP) have magnified the declines of the broader stock indexes late last year. This is typical for a brand new speculative industry that is still trying to find its footing and is a long way from any sort of stable revenue. Still, two out of the three, CRISPR and Editas, remain significantly higher than

126 Views    Matt Winkler    2019-04-17 16:10
CRISPR stocks have been plagued with clinical holds by the FDA. But what if the treatments these speculative companies are working on can be applied in utero? New research shows they can

Genetic disorders are quite a daunting disease group to treat, but there is one major overlooked advantage in developing treatments for this disease group over others. Genetic diseases can be screened for in utero. So what? Thanks to new research published in the journal Nature Medicine, we know that they can be treated in utero as well.

This could have profound implications for the CRISPR gene-editing investment space, because it could change the regulatory landscape for the whole CRISPR approach to treatment. For better or for worse, fetuses do not have the same rights as those already born, and

244 Views    Matt Winkler    2018-10-14 17:34
Stanford Scientists succeeded in editing out an amyotrophic lateral sclerosis gene in human cell cultures. Here's why CRISPR-cas9 gene editing could change the process of drug discovery

Could the CRISPR-cas9 gene-editing system be the key to a cure for amyotrophic lateral sclerosis (ALS)? A new paper written by a group of Stanford graduate students and just published in the journal Nature Genetics suggests a very hopeful maybe. Here’s the background.

Back in 2011, a paper was published delineating the cause of ALS, at least in a group of families with a proven autosomal dominant genetic feature. The cause in these cases is a repeating series of six nucleotides in a gene called C9orf72. It’s sort of like a broken record in the gene, or a

334 Views    Matt Winkler    2018-03-12 14:32
Four Polish scientists just discovered a way to edit genes with CRISPR with high precision. Past CRISPR tech has hit public markets very quickly, and this new innovation may do so soon as well.

The CRISPR-cas9 gene editing technique is one of the most exciting advances in genomics since Watson and Crick discovered the chemical structure of DNA in 1953. Basically, it allows the selective editing of genes, potentially allowing humans to fix errors that cause genetic diseases and any other number of science fiction-like applications.

The main problem is CRISPR can cause mistakes in DNA after the cut strands are excised and the rest glued back together. This can lead to transcription problems, causing unforeseeable issues. That makes it very scary to apply for practical purposes because new errors can cause worse problems

308 Views    Matt Winkler    2018-03-02 20:29

Headlines Total 129
  • 1
  • 2

2020-10-24
8:55am
2020-10-22 $ 90.16 (-2.23%)
5:41pm
12:11pm
10:22am
2020-10-21 $ 92.22 (-13.57%)
5:58pm
12:19pm
7:01am
2020-10-15 $ 99.89 (-1.46%)
10:18am
9:11am
2020-10-12 $ 99.4 (1.16%)
2:30pm
8:45am
2020-10-09 $ 98.26 (3.01%)
9:14am
2020-10-07 $ 97.68 (11.35%)
5:05pm
11:00am
2020-10-03
7:38am
2020-09-30 $ 83.64 (-1.59%)
6:45am
2020-09-29 $ 84.99 (1.55%)
11:00am
2020-09-24 $ 83.31 (-1.63%)
6:04am
2020-09-23 $ 84.69 (-4.64%)
10:03am
2020-09-22 $ 88.81 (4.32%)
11:01am
2020-09-18 $ 85.9 (0.89%)
12:45pm
2020-09-11 $ 79.98 (-2.22%)
5:44pm
2020-09-10 $ 81.8 (-4.05%)
6:55am
2020-09-09 $ 85.25 (4.65%)
4:26pm
7:04am
2020-09-03 $ 85.69 (-8.77%)
11:02am
2020-09-02 $ 93.93 (0.55%)
9:49am
2020-08-26 $ 88.91 (-0.01%)
10:30am
2020-08-20 $ 91.76 (-8.82%)
7:33am
2020-08-14 $ 89.5 (-2.44%)
2:55pm
2020-08-05 $ 94.51 (-0.06%)
5:15pm
2020-07-31 $ 85.46 (-1.04%)
11:33am
2020-07-30 $ 86.36 (0.97%)
11:00am
2020-07-27 $ 92.12 (1.96%)
5:15pm
11:31am
9:18am
2020-07-26
8:10am
2020-07-25
6:45am
2020-07-21 $ 93.55 (-1.84%)
7:07am
2020-07-17 $ 92.35 (1.13%)
10:11am
2020-07-08 $ 94.17 (3.02%)
1:35pm
2020-07-02 $ 79.7 (1.53%)
7:43am
2020-07-01 $ 73.49 (-2.08%)
11:00pm
2020-06-30 $ 75.05 (1.36%)
7:00pm
2020-06-29 $ 75.05 (1.36%)
1:04am
2020-06-28
7:36am
2020-06-26 $ 74.04 (-2.64%)
4:15pm
2020-06-25 $ 76.05 (4.05%)
11:00am
2020-06-23 $ 75.37 (4.65%)
4:08pm
2020-06-14
6:00am
2020-06-12 $ 59.89 (0.32%)
2:12pm
12:54pm
3:00am
2020-06-03 $ 64.95 (-4.99%)
5:15pm
7:54am
7:02am
2020-06-01 $ 66.59 (3.11%)
2:28pm
2020-05-28 $ 62.31 (-2.53%)
10:31am
2020-05-26 $ 66.34 (-5.15%)
11:06am
2020-05-21 $ 67.78 (1.48%)
4:15pm
2020-05-19 $ 63.56 (-0.66%)
4:09am
2020-05-16
10:00am
2020-05-15 $ 61.09 (9.32%)
11:03am
2020-05-14 $ 55.88 (-2.6%)
11:06am
2020-05-13 $ 57.37 (-3.66%)
4:15pm
3:50pm
2020-05-11 $ 61.29 (13.84%)
5:19pm
11:00am
2020-05-07 $ 53.49 (2.22%)
11:01am
2020-04-30 $ 49.2 (-5.38%)
11:44am
6:27am
2020-04-29 $ 52.52 (-4.51%)
7:00pm
2020-04-28 $ 52.52 (-4.51%)
6:45pm
2020-04-27 $ 55 (1.83%)
11:31am
11:00am
2020-04-22 $ 52.4 (2.95%)
6:24am
2020-04-10 $ 45.75 (%)
12:30pm
2020-04-06 $ 42.17 (7.08%)
10:32am
2020-04-05
8:07am
2020-02-27 $ 50.88 (1.98%)
7:01pm
2020-01-07 $ 59.95 (0.86%)
7:00pm
2019-11-27 $ 68.11 (-0.95%)
7:00am
2019-11-21 $ 67.42 (-1.52%)
11:00pm
2019-11-20 $ 68.46 (16.97%)
7:00pm
2019-11-19 $ 68.46 (16.97%)
7:00am
2019-11-14 $ 55.06 (0.11%)
6:38am
2019-10-28 $ 44.85 (12.55%)
7:00am
2019-10-15 $ 37.96 (3.49%)
7:00am
2019-10-01 $ 38.53 (-6%)
7:00am
2019-09-17 $ 49.22 (-0.91%)
7:00am
2019-07-31 $ 50.69 (-0.06%)
7:02am
2019-07-30 $ 51.32 (-1.16%)
7:01pm
2019-07-02 $ 47.71 (1.3%)
7:02pm
2019-05-29 $ 36.86 (0.38%)
7:00am
2019-05-01 $ 38.82 (-3.41%)
7:00am
2019-04-30 $ 40.28 (-1.8%)
7:01pm
2019-04-17 $ 36.43 (-6.78%)
11:00am
2019-04-16 $ 39.08 (5.2%)
7:00am
2019-04-01 $ 35.45 (-0.76%)
7:01am
2019-03-06 $ 38.39 (-6.07%)
7:02am
Total 129
  • 1
  • 2